Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
185.95
3.75 (2.06%)
BSENSE

Jun 18

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kopran
Wanbury
Anlon Healthcare
Shree Ganesh Rem
Kilitch Drugs
Anuh Pharma
Themis Medicare
Sigachi Indust.
Bharat Parenter.
Fermenta Biotec.
Remus Pharma.
Why is Kopran Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.17 times
2
Poor long term growth as Operating profit has grown by an annual rate -10.07% of over the last 5 years
3
The company has declared positive results in Mar'2026 after 6 consecutive negative quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 10.39 times
  • NET SALES(Q) Highest at Rs 234.02 cr
  • PBDIT(Q) Highest at Rs 32.95 cr.
4
Stock is technically in a Mildly Bullish range
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
With ROCE of 6.2, it has a Attractive valuation with a 1.4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.21%, its profits have fallen by -33.3%
6
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Kopran should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Kopran for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Kopran
-2.08%
0.03
46.34%
Sensex
-5.06%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.74%
EBIT Growth (5y)
-10.07%
EBIT to Interest (avg)
7.62
Debt to EBITDA (avg)
1.77
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
1.03
Tax Ratio
25.09%
Dividend Payout Ratio
37.57%
Pledged Shares
0
Institutional Holding
0.57%
ROCE (avg)
10.55%
ROE (avg)
8.64%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
34
Price to Book Value
1.66
EV to EBIT
24.37
EV to EBITDA
17.22
EV to Capital Employed
1.52
EV to Sales
1.51
PEG Ratio
NA
Dividend Yield
1.65%
ROCE (Latest)
6.23%
ROE (Latest)
4.85%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 10.39 times

NET SALES(Q)

Highest at Rs 234.02 cr

PBDIT(Q)

Highest at Rs 32.95 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 14.08%

PBT LESS OI(Q)

Highest at Rs 25.26 cr.

PAT(Q)

Highest at Rs 18.87 cr.

EPS(Q)

Highest at Rs 3.91

-7What is not working for the Company
PAT(9M)

At Rs 18.29 cr has Grown at -33.39%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 7.22 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.59 times

INTEREST(Q)

Highest at Rs 3.17 cr

Loading Valuation Snapshot...
Here's what is working for Kopran
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 25.26 cr has Grown at 141.72%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 18.87 cr has Grown at 94.9%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 10.39 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 234.02 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 234.02 cr has Grown at 35.77%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 32.95 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 14.08%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 25.26 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 18.87 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 3.91
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Kopran
Interest - Quarterly
Highest at Rs 3.17 cr
in the last five quarters and Increased by 18.73 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 7.22 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Lowest at 2.59 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio